annual total liabilities:
$8.41B+$1.30B(+18.27%)Summary
- As of today (May 29, 2025), REGN annual total liabilities is $8.41 billion, with the most recent change of +$1.30 billion (+18.27%) on December 31, 2024.
- During the last 3 years, REGN annual total liabilities has risen by +$1.74 billion (+26.10%).
- REGN annual total liabilities is now at all-time high.
Performance
REGN Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$8.16B-$248.20M(-2.95%)Summary
- As of today (May 29, 2025), REGN quarterly total liabilities is $8.16 billion, with the most recent change of -$248.20 million (-2.95%) on March 31, 2025.
- Over the past year, REGN quarterly total liabilities has increased by +$779.10 million (+10.56%).
- REGN quarterly total liabilities is now -2.95% below its all-time high of $8.41 billion, reached on December 31, 2024.
Performance
REGN quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
REGN Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.3% | +10.6% |
| 3 y3 years | +26.1% | +26.8% |
| 5 y5 years | +126.2% | +125.1% |
REGN Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.3% | -3.0% | +30.8% |
| 5 y | 5-year | at high | +126.2% | -3.0% | +125.1% |
| alltime | all time | at high | >+9999.0% | -3.0% | >+9999.0% |
REGN Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $8.16B(-3.0%) |
| Dec 2024 | $8.41B(+18.3%) | $8.41B(+3.6%) |
| Sep 2024 | - | $8.12B(+3.0%) |
| Jun 2024 | - | $7.88B(+6.8%) |
| Mar 2024 | - | $7.38B(+3.8%) |
| Dec 2023 | $7.11B(+8.5%) | $7.11B(-2.1%) |
| Sep 2023 | - | $7.26B(+9.3%) |
| Jun 2023 | - | $6.64B(+1.1%) |
| Mar 2023 | - | $6.56B(+0.2%) |
| Dec 2022 | $6.55B(-1.7%) | $6.55B(+5.0%) |
| Sep 2022 | - | $6.24B(-4.3%) |
| Jun 2022 | - | $6.52B(+1.3%) |
| Mar 2022 | - | $6.43B(-3.5%) |
| Dec 2021 | $6.67B(+8.6%) | $6.67B(+3.9%) |
| Sep 2021 | - | $6.41B(+0.9%) |
| Jun 2021 | - | $6.36B(+9.7%) |
| Mar 2021 | - | $5.80B(-5.6%) |
| Dec 2020 | $6.14B(+65.2%) | $6.14B(+3.0%) |
| Sep 2020 | - | $5.96B(+10.9%) |
| Jun 2020 | - | $5.37B(+48.2%) |
| Mar 2020 | - | $3.62B(-2.4%) |
| Dec 2019 | $3.72B(+24.8%) | $3.72B(+8.2%) |
| Sep 2019 | - | $3.43B(+0.5%) |
| Jun 2019 | - | $3.42B(+0.2%) |
| Mar 2019 | - | $3.41B(+14.5%) |
| Dec 2018 | $2.98B(+13.6%) | $2.98B(+1.4%) |
| Sep 2018 | - | $2.94B(+6.2%) |
| Jun 2018 | - | $2.77B(-1.4%) |
| Mar 2018 | - | $2.81B(+7.1%) |
| Dec 2017 | $2.62B(+3.8%) | $2.62B(-1.1%) |
| Sep 2017 | - | $2.65B(+2.5%) |
| Jun 2017 | - | $2.59B(-12.4%) |
| Mar 2017 | - | $2.95B(+16.9%) |
| Dec 2016 | $2.52B(+29.2%) | $2.52B(+8.0%) |
| Sep 2016 | - | $2.34B(+9.8%) |
| Jun 2016 | - | $2.13B(-0.5%) |
| Mar 2016 | - | $2.14B(+9.5%) |
| Dec 2015 | $1.95B(+51.8%) | $1.95B(+3.6%) |
| Sep 2015 | - | $1.89B(+58.7%) |
| Jun 2015 | - | $1.19B(-3.1%) |
| Mar 2015 | - | $1.23B(-4.7%) |
| Dec 2014 | $1.29B(+28.9%) | $1.29B(+8.4%) |
| Sep 2014 | - | $1.19B(+9.2%) |
| Jun 2014 | - | $1.09B(+3.6%) |
| Mar 2014 | - | $1.05B(+5.0%) |
| Dec 2013 | $998.94M(+19.6%) | $998.94M(+5.1%) |
| Sep 2013 | - | $950.24M(+7.4%) |
| Jun 2013 | - | $884.92M(+1.8%) |
| Mar 2013 | - | $869.65M(+4.1%) |
| Dec 2012 | $835.11M(-0.3%) | $835.11M(-2.3%) |
| Sep 2012 | - | $854.59M(-1.0%) |
| Jun 2012 | - | $862.84M(+2.0%) |
| Mar 2012 | - | $846.13M(+1.0%) |
| Dec 2011 | $837.85M(+49.2%) | $837.85M(+51.0%) |
| Sep 2011 | - | $554.78M(-2.5%) |
| Jun 2011 | - | $568.83M(+2.3%) |
| Mar 2011 | - | $556.20M(-1.0%) |
| Dec 2010 | $561.62M(+63.1%) | $561.62M(-5.5%) |
| Sep 2010 | - | $594.37M(+41.7%) |
| Jun 2010 | - | $419.43M(+4.6%) |
| Mar 2010 | - | $400.88M(+16.4%) |
| Dec 2009 | $344.44M(+13.8%) | $344.44M(+7.7%) |
| Sep 2009 | - | $319.75M(-3.6%) |
| Jun 2009 | - | $331.84M(+22.4%) |
| Mar 2009 | - | $271.10M(-10.4%) |
| Dec 2008 | $302.71M | $302.71M(-22.2%) |
| Sep 2008 | - | $388.96M(-2.8%) |
| Jun 2008 | - | $400.23M(-14.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $470.27M(-1.2%) |
| Dec 2007 | $475.99M(+29.2%) | $475.99M(+12.9%) |
| Sep 2007 | - | $421.70M(+0.8%) |
| Jun 2007 | - | $418.52M(+3.4%) |
| Mar 2007 | - | $404.74M(+9.8%) |
| Dec 2006 | $368.47M(+19.1%) | $368.47M(+25.9%) |
| Sep 2006 | - | $292.71M(-0.6%) |
| Jun 2006 | - | $294.56M(-1.7%) |
| Mar 2006 | - | $299.77M(-3.1%) |
| Dec 2005 | $309.50M(+6.5%) | $309.50M(+9.4%) |
| Sep 2005 | - | $282.89M(+0.4%) |
| Jun 2005 | - | $281.89M(-0.9%) |
| Mar 2005 | - | $284.51M(-2.1%) |
| Dec 2004 | $290.56M(-15.0%) | $290.56M(-1.1%) |
| Sep 2004 | - | $293.81M(-1.4%) |
| Jun 2004 | - | $298.04M(-1.3%) |
| Mar 2004 | - | $302.07M(-11.7%) |
| Dec 2003 | $341.91M(+39.2%) | $341.91M(-0.7%) |
| Sep 2003 | - | $344.30M(+33.6%) |
| Jun 2003 | - | $257.70M(-2.7%) |
| Mar 2003 | - | $264.83M(+7.8%) |
| Dec 2002 | $245.59M(+7.2%) | $245.59M(+3.3%) |
| Sep 2002 | - | $237.80M(+4.6%) |
| Jun 2002 | - | $227.29M(-0.9%) |
| Mar 2002 | - | $229.38M(+0.1%) |
| Dec 2001 | $229.04M(+776.1%) | $229.04M(+864.7%) |
| Sep 2001 | - | $23.74M(+3.2%) |
| Jun 2001 | - | $23.00M(-7.2%) |
| Mar 2001 | - | $24.77M(-5.2%) |
| Dec 2000 | $26.14M(-4.9%) | $26.14M(+3.1%) |
| Sep 2000 | - | $25.35M(-3.1%) |
| Jun 2000 | - | $26.15M(-1.1%) |
| Mar 2000 | - | $26.44M(-3.9%) |
| Dec 1999 | $27.50M(+7.0%) | $27.50M(+15.1%) |
| Sep 1999 | - | $23.90M(-2.0%) |
| Jun 1999 | - | $24.40M(-5.8%) |
| Mar 1999 | - | $25.90M(+0.8%) |
| Dec 1998 | $25.70M(-12.9%) | $25.70M(+0.8%) |
| Sep 1998 | - | $25.50M(-6.6%) |
| Jun 1998 | - | $27.30M(+5.0%) |
| Mar 1998 | - | $26.00M(-11.9%) |
| Dec 1997 | $29.50M(-3.9%) | $29.50M(+11.3%) |
| Sep 1997 | - | $26.50M(-12.0%) |
| Jun 1997 | - | $30.10M(+7.1%) |
| Mar 1997 | - | $28.10M(-8.5%) |
| Dec 1996 | $30.70M(+18.5%) | $30.70M(+16.3%) |
| Sep 1996 | - | $26.40M(-0.4%) |
| Jun 1996 | - | $26.50M(+10.0%) |
| Mar 1996 | - | $24.10M(-6.9%) |
| Dec 1995 | $25.90M(-4.4%) | $25.90M(+22.2%) |
| Sep 1995 | - | $21.20M(-11.7%) |
| Jun 1995 | - | $24.00M(+7.6%) |
| Mar 1995 | - | $22.30M(-17.7%) |
| Dec 1994 | $27.10M(+41.1%) | $27.10M(+10.2%) |
| Sep 1994 | - | $24.60M(-15.5%) |
| Jun 1994 | - | $29.10M(+50.8%) |
| Mar 1994 | - | $19.30M(+0.5%) |
| Dec 1993 | $19.20M(+79.4%) | $19.20M(+21.5%) |
| Sep 1993 | - | $15.80M(+12.9%) |
| Jun 1993 | - | $14.00M(+9.4%) |
| Mar 1993 | - | $12.80M(+19.6%) |
| Dec 1992 | $10.70M(+37.2%) | $10.70M(-1.8%) |
| Sep 1992 | - | $10.90M(+16.0%) |
| Jun 1992 | - | $9.40M(+2.2%) |
| Mar 1992 | - | $9.20M(+17.9%) |
| Dec 1991 | $7.80M(-40.9%) | $7.80M(+39.3%) |
| Sep 1991 | - | $5.60M(-5.1%) |
| Jun 1991 | - | $5.90M(-55.3%) |
| Dec 1990 | $13.20M | $13.20M |
FAQ
- What is Regeneron Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual total liabilities year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly total liabilities year-on-year change?
What is Regeneron Pharmaceuticals annual total liabilities?
The current annual total liabilities of REGN is $8.41B
What is the all time high annual total liabilities for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total liabilities is $8.41B
What is Regeneron Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, REGN annual total liabilities has changed by +$1.30B (+18.27%)
What is Regeneron Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of REGN is $8.16B
What is the all time high quarterly total liabilities for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total liabilities is $8.41B
What is Regeneron Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, REGN quarterly total liabilities has changed by +$779.10M (+10.56%)